Statistics
Publications
2
Citations
9.5K
H-Index
2
Active since
2015
Affiliations
H. Borghaei is an author at Fox Chase Cancer Center specializing in programmed death-1 blockade, cancer immunotherapy, and pd-1 signaling.
Publications per year
2015–2022
2
2
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.5K citations · Full text
1–2 of 2